Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Glutamate Ionotropic Kainate Receptors as Therapeutic Targets in Enzalutamide-Resistant and Neuroendocrine Prostate Cancer.
Journal: International journal of molecular sciences
Published: May 30, 2026
Real-world effectiveness of darolutamide in metastatic castration-resistant prostate cancer.
Journal: Endocrine-related cancer
Published: February 24, 2025
Functional inversion of circadian regulator REV-ERBα leads to tumorigenic gene reprogramming.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 09, 2024
PINK1-Mediated Mitochondrial Activity Confers Olaparib Resistance in Prostate Cancer Cells.
Journal: Cancer research communications
Published: June 20, 2024
Retraction: Nuclear Factor-κB p65 Mediates Tumor Necrosis Factor α-induced Nuclear Translocation of Telomerase Reverse Transcriptase Protein.
Journal: Cancer research
Published: March 15, 2024
Retraction: Insulin-like Growth Factor-1 Induces Adhesion and Migration in Human Multiple Myeloma Cells via Activation of β1-Integrin and Phosphatidylinositol 3'-Kinase/AKT Signaling.
Journal: Cancer research
Published: March 15, 2024
Retraction: Cytokines Modulate Telomerase Activity in a Human Multiple Myeloma Cell Line.
Journal: Cancer research
Published: March 15, 2024
Author Correction: Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity.
Journal: Nature medicine
Published: February 15, 2024
Enhancing cancer immunotherapy via inhibition of soluble epoxide hydrolase.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 08, 2024
LX1 Dual Targets AR Variants and AKR1C3 in Advanced Prostate Cancer Therapy.
Journal: Cancer research
Published: February 05, 2024
Last Updated: 09/26/2026